DiscoverPHASE3The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics
The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics

The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics

Update: 2024-08-13
Share

Description

We speak to Dimerix CEO Dr Nina Webster about why investors are thrilled with her company, as it nears the midway point for its Phase III clinical trial for the rare disease focal segmental glomerulosclerosis (FSGS).

And we talk to PYC Therapeutics CEO Dr Rohan Hockings about how his company's tech actually works to treat polycystic kidney disease.  

Support the show

Produced by Rachel Williamson and Charis Palmer. Music and effect credits to Ziso, Inspector J, Seth Parson and Boom Library.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics

The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics

Soundcraft Media